TABLE 3

Indications to initiate treatment for chronic lymphocytic leukemia

Constitutional symptoms attributable to the disease
Progressive marrow failure
Autoimmune anemia or thrombocytopenia poorly responsive to corticosteroids
Massive or progressive splenomegaly
Massive or progressive lymphadenopathy
Rapid lymphocyte doubling time
  • Based on information in reference 30.